Skip to main content
Nature Communications logoLink to Nature Communications
. 2018 Feb 9;9:670. doi: 10.1038/s41467-018-02947-0

Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia

Xi Jiang 1,2,3,, Chao Hu 1,2,4, Kyle Ferchen 1, Ji Nie 5, Xiaolong Cui 5, Chih-Hong Chen 6, Liting Cheng 7, Zhixiang Zuo 1,8, William Seibel 9, Chunjiang He 10, Yixuan Tang 7, Jennifer R Skibbe 1, Mark Wunderlich 11, William C Reinhold 12, Lei Dong 1,3, Chao Shen 1,3, Stephen Arnovitz 2, Bryan Ulrich 2, Jiuwei Lu 1, Hengyou Weng 1,2,3, Rui Su 1,3, Huilin Huang 1,3, Yungui Wang 1,2,4, Chenying Li 1,3,4, Xi Qin 1,3, James C Mulloy 11, Yi Zheng 11, Jiajie Diao 1, Jie Jin 4, Chong Li 7, Paul P Liu 13, Chuan He 5, Yuan Chen 6, Jianjun Chen 1,2,3,
PMCID: PMC5807514  PMID: 29426862

Correction to: Nature Communications 10.1038/s41467-017-02290-w; published online: 13 Dec 2017

The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.

Footnotes

The original article can be found online at 10.1038/s41467-017-02290-w.

Contributor Information

Xi Jiang, Email: xjiang@coh.org.

Jianjun Chen, Email: jianchen@coh.org.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES